Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul W. Huber has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Synonymous codon substitutions modulate transcription and translation of a divergent upstream gene by modulating antisense RNA production

    by Anabel Rodriguez, Jacob D. Diehl, Gabriel S. Wright, Christopher D. Bonar, Taylor J. Lundgren, McKenze J. Moss, Jun Li, Tijana Milenkovic, Paul W. Huber, Matthew M. Champion, et al.

    Synonymous codons were originally viewed as interchangeable, with no phenotypic consequences. However, substantial evidence has now demonstrated that synonymous substitutions can perturb a variety of gene expression and protein homeostasis mechanisms, including translational efficiency, translational fidelity, and cotranslational folding of the encoded protein. To date, most studies of synonymous codon-derived perturbations have focused on effects within a single gene. Here, we show that synonymous codon substitutions made far within the coding sequence ofEscherichia coliplasmid-encoded chloramphenicol acetyltransferase (cat) can significantly increase expression of the divergent upstream tetracycline resistance gene,tetR. In four out of nine synonymously recodedcatsequences tested, expression of the upstreamtetRgene was significantly elevated due to transcription of a long antisense RNA (asRNA) originating from a transcription start site withincat. Surprisingly, transcription of this asRNA readily bypassed the nativetettranscriptional repression mechanism. Even more surprisingly, accumulation of the TetR protein correlated with the level of asRNA, rather than totaltetRRNA. These effects of synonymous codon substitutions on transcription and translation of a neighboring gene suggest that synonymous codon usage in bacteria may be under selection to both preserve the amino acid sequence of the encoded gene and avoid DNA sequence elements that can significantly perturb expression of neighboring genes. Avoiding such sequences may be especially important in plasmids and prokaryotic genomes, where genes and regulatory elements are often densely packed. Similar considerations may apply to the design of genetic circuits for synthetic biology applications.


  • Open Access

    Remnants of the Balbiani body are required for formation of RNA transport granules in Xenopus oocytes

    by Chao Yang, Gena M. Dominique, Matthew M. Champion, Paul W. Huber


  • Open Access

    Proteomic and Transcriptomic Analysis of Neural Cell Fate in Developing Xenopus Embryos

    by Owen Ivan, Kyle Dubiak, Norman Dovichi, Paul Huber

    The progeny of the D1 blastomere in the 8‐cell X. laevis embryo make major contributions to the central nervous system, brain, and retina of the adult animal. The lineage of this cell was tracked at the protein and mRNA levels at seven developmental time points up to the mid‐neurula stage. In addition, descendant cells from an excised D1 blastomere were analyzed at the same developmental stages. Transcriptomic analysis reveals that at early neurulation, the progeny tissue has committed to the expected neural fate, whereas the explant tissue has begun to differentiate into non‐neural ectoderm/epidermis. Bioinformatics analysis indicates that Notch signaling through the Jagged 1 (Jag1), Jagged 2 (Jag2), and Delta‐like 1 (Dll1) ligands is critical for determining the neural fate of the D1 progeny in the intact embryo. This study has also revealed a considerable amount of regulation at the level of translation. Notable examples include REST and Churchill. While the mRNA encoding these proteins is found in D1 progeny of the intact embryo and the explant tissue, REST protein, a repressor of neural gene expression, was only detected in explant tissue. Conversely, Churchill protein, involved in neural induction, was only detected in D1 progeny from the intact embryo. Continued bioinformatics analysis of the data generated by the strategy used here has three specific aims: 1. Identification of other intercellular signaling pathways that determine the neural fate of D1 progeny; 2. Identification of novel gene products that direct neurogenesis; 3. Identification of translational regulators (RNA binding proteins and miRNAs) of neural‐specific transcripts.

  • Open Access

    Remnants of the Balbiani body are required for formation of RNA transport granules in Xenopus oocytes

    by Chao Yang, Gena M. Wilson, Matthew M. Champion, Paul W. Huber

    Fragmentation of the Balbiani body in Xenopus oocytes engenders a region extending from the germinal vesicle (GV) towards the vegetal pole that is enriched in mitochondria. This area is later transversed by RNA that is being localized to the vegetal cortex. Inhibition of mitochondrial ATP synthesis prevents the perinuclear formation of these RNA transport granules that can be reversed by the nonhydrolyzable ATP analog, adenosine 5’-(βγ-imido) triphosphate. The protein composition and sensitivity of the transport granules to hexanediol indicate that they are liquid phase condensates. Mitochondria in the remnants of the Balbiani body produce a region of elevated ATP that appears to act as a hydrotrope to support the perinuclear phase transition leading to granule formation. Summary: Mitochondria in the remnants of the Balbiani body produce elevated levels of ATP required for the formation of liquid phase condensates containing RNA transport granules.

  • Open Access

    Developing Practical Therapeutic Strategies that Target Protein SUMOylation

    by Olivia F. Cox, Paul W. Huber

    Post-translational modification by small ubiquitin-like modifier (SUMO) has emerged as a global mechanism for the control and integration of a wide variety of biological processes through the regulation of protein activity, stability and intracellular localization. As SUMOylation is examined in greater detail, it has become clear that the process is at the root of several pathologies including heart, endocrine, and inflammatory disease, and various types of cancer. Moreover, it is certain that perturbation of this process, either globally or of a specific protein, accounts for many instances of congenital birth defects. In order to be successful, practical strategies to ameliorate conditions due to disruptions in this post-translational modification will need to consider the multiple components of the SUMOylation machinery and the extraordinary number of proteins that undergo this modification.


  • Open Access

    A deficiency in SUMOylation activity disrupts multiple pathways leading to neural tube and heart defects in Xenopus embryos

    by Michelle M. Bertke, Kyle M. Dubiak, Laura Cronin, Erliang Zeng, Paul W. Huber

    Background: Adenovirus protein, Gam1, triggers the proteolytic destruction of the E1 SUMO-activating enzyme. Microinjection of an empirically determined amount of Gam1 mRNA into one-cellXenopusembryos can reduce SUMOylation activity to undetectable, but nonlethal, levels, enabling an examination of the role of this post-translational modification during early vertebrate development.Results: We find that SUMOylation-deficient embryos consistently exhibit defects in neural tube and heart development. We have measured differences in gene expression between control and embryos injected with Gam1 mRNA at three developmental stages: early gastrula (immediately following the initiation of zygotic transcription), late gastrula (completion of the formation of the three primary germ layers), and early neurula (appearance of the neural plate). Although changes in gene expression are widespread and can be linked to many biological processes, three pathways, non-canonical Wnt/PCP, snail/twist, and Ets-1, are especially sensitive to the loss of SUMOylation activity and can largely account for the predominant phenotypes of Gam1 embryos. SUMOylation appears to generate different pools of a given transcription factor having different specificities with this post-translational modification involved in the regulation of more complex, as opposed to housekeeping, processes.Conclusions: We have identified changes in gene expression that underlie the neural tube and heart phenotypes resulting from depressed SUMOylation activity. Notably, these developmental defects correspond to the two most frequently occurring congenital birth defects in humans, strongly suggesting that perturbation of SUMOylation, either globally or of a specific protein, may frequently be the origin of these pathologies.


  • Open Access

    A Deficiency in SUMOylation Activity Disrupts Multiple Pathways Leading to Neural Tube and Heart Defects inXenopusEmbryos

    by Michelle M. Bertke, Kyle M. Dubiak, Laura Cronin, Erliang Zeng, Paul W. Huber

    Background: Adenovirus protein, Gam1, triggers the proteolytic destruction of the E1 SUMO-activating enzyme. Microinjection of an empirically determined amount of Gam1 mRNA into one-cellXenopusembryos can reduce SUMOylation activity to undetectable, but nonlethal, levels, enabling an examination of the role of this post-translational modification during early vertebrate development.Results: We find that SUMOylation-deficient embryos consistently exhibit defects in neural tube and heart development. We have measured differences in gene expression between control and embryos injected with Gam1 mRNA at three developmental stages: early gastrula (immediately following the initiation of zygotic transcription), late gastrula (completion of the formation of the three primary germ layers), and early neurula (appearance of the neural plate). Although changes in gene expression are widespread and can be linked to many biological processes, three pathways, non-canonical Wnt/PCP, snail/twist, and Ets-1, are especially sensitive to the loss of SUMOylation activity and can largely account for the predominant phenotypes of Gam1 embryos. SUMOylation appears to generate different pools of a given transcription factor having different specificities with this post-translational modification involved in the regulation of more complex, as opposed to housekeeping, processes.Conclusions: We have identified changes in gene expression that underlie the neural tube and heart phenotypes resulting from depressed SUMOylation activity. Notably, these developmental defects correspond to the two most frequently occurring congenital birth defects in humans, strongly suggesting that perturbation of SUMOylation, either globally or of a specific protein, may frequently be the origin of these pathologies.

  • Open Access

    Author Correction: Phosphorylation Dynamics Dominate the Regulated Proteome during Early Xenopus Development

    by Elizabeth H. Peuchen, Olivia F. Cox, Liangliang Sun, Alex S. Hebert, Joshua J. Coon, Matthew M. Champion, Norman J. Dovichi, Paul W. Huber

    A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

  • Open Access

    Phosphorylation Dynamics Dominate the Regulated Proteome during Early Xenopus Development

    by Elizabeth H. Peuchen, Olivia F. Cox, Liangliang Sun, Alex S. Hebert, Joshua J. Coon, Matthew M. Champion, Norman J. Dovichi, Paul W. Huber

    The earliest stages of animal development are largely controlled by changes in protein phosphorylation mediated by signaling pathways and cyclin-dependent kinases. In order to decipher these complex networks and to discover new aspects of regulation by this post-translational modification, we undertook an analysis of the X. laevis phosphoproteome at seven developmental stages beginning with stage VI oocytes and ending with two-cell embryos. Concurrent measurement of the proteome and phosphoproteome enabled measurement of phosphosite occupancy as a function of developmental stage. We observed little change in protein expression levels during this period. We detected the expected phosphorylation of MAP kinases, translational regulatory proteins, and subunits of APC/C that validate the accuracy of our measurements. We find that more than half the identified proteins possess multiple sites of phosphorylation that are often clustered, where kinases work together in a hierarchical manner to create stretches of phosphorylated residues, which may be a means to amplify signals or stabilize a particular protein conformation. Conversely, other proteins have opposing sites of phosphorylation that seemingly reflect distinct changes in activity during this developmental timeline.


  • Tetrahydrofuranyl and tetrahydropyranyl protection of amino acid side-chains enables synthesis of a hydroxamate-containing aminoacylated tRNA

    by Lester J. Lambert, Marvin J. Miller, Paul W. Huber

    The ability to specifically engineer metal binding sites into target proteins has far-reaching consequences ranging from the development of new biocatalysts and imaging reagents to the production of proteins with increased stability. We report the efficient tRNA-mediated incorporation of the hydroxamate containing amino acid, Nε-acetyl-Nε-hydroxy-L-lysine, into a transcription factor (TFIIIA). Because this amino acid is compact, hydrophilic, and uncharged at physiological pH, it should have little or no effect on protein folding or solubility. The Nε-hydroxy group of the hydroxamate is refractory to photodeprotection and required the identification of reagents for O-protection that are compatible with the synthesis of acylated tRNA. Tetrahydrofuranyl and tetrahydropyranyl O-protecting groups can be removed using mild acid conditions and allowed for an orthogonal protection strategy in which deprotection of the amino acid side chain precedes ligation of an acylated dinucleotide to a truncated suppressor tRNA. These protecting groups will provide a valuable alternative for O-protection, especially in cases where photodeprotection cannot be used.